0001469559-12-000010 Sample Contracts

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • March 13th, 2012 • Proteonomix, Inc. • Pharmaceutical preparations

This Registration Rights Agreement (this “Agreement”) is made and entered into as of February __, 2012, between Proteonomix, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

AutoNDA by SimpleDocs
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 13th, 2012 • Proteonomix, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of March __, 2012, between Proteonomix, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

SERIES B COMMON STOCK PURCHASE WARRANT
Proteonomix, Inc. • March 13th, 2012 • Pharmaceutical preparations

THIS SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ______________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the 1 year, 2 week anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Proteonomix, Inc., a Delaware corporation (the “Company”), up to _____ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

SERIES C COMMON STOCK PURCHASE WARRANT
Proteonomix, Inc. • March 13th, 2012 • Pharmaceutical preparations

THIS SERIES C COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _______________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the exercise of the Series B Common Stock Purchase Warrant held by the Holder (or its permitted assigns) (the “Initial Exercise Date”) and on or prior to the close of business on the 5 year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Proteonomix, Inc., a Delaware corporation (the “Company”), up to _______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock; provided, however, the exercisability of this Series C Warrant shall vest ratably from time to time in proportion to the Holder’s (or its permitted assigns) exercise of the Series B Common Stock Purchase Warrant as compared with all Series B Comm

RODMAN & RENSHAW, LLC
Proteonomix, Inc. • March 13th, 2012 • Pharmaceutical preparations • New York
Time is Money Join Law Insider Premium to draft better contracts faster.